Fredun Pharmaceuticals Current Share Price | Fredun Pharmaceuticals Stock Screener
FREDUN
Pharmaceuticals
Fredun Pharmaceuticals Current Stock Price Today
Live Share Price NSE
₹1303.50
▲
25.30 (1.98%)
Live Share Price BSE
₹1305.85
▲
27.20 (2.13%)
As of September 18, 2026, the live Fredun Pharmaceuticals share price (NSE: FREDUN) is ₹1,303.50 on NSE and ₹1,305.85 on BSE, up 1.98% from the previous close, with shares trading between ₹1,288.10 and ₹1,324.00 in today's trading session, and a 52-week range of ₹1,221.60–₹1,505.80.
Browse FREDUN cash flow statement to support your investment research.
Use the Fredun Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Fredun Pharmaceuticals Market Cap
₹2,247.03 Cr.
FREDUN P/E Ratio (TTM)
53.34
Fredun Pharmaceuticals P/B Ratio
9.01
EPS (TTM)
₹66.81
Dividend Yield
0.02%
Debt to Equity
0.93
FREDUN 52 Week High
₹1505.80
Fredun Pharmaceuticals 52 Week Low
₹1221.60
Operating Margin
14.00%
Profit Margin
5.70%
FREDUN Revenue (TTM)
₹228.00
EBITDA
₹32.00
Net Income
₹13.00
Total Assets
₹642.00
Total Equity
₹278.00
Fredun Pharmaceuticals Current Share Price Chart
Track the current Fredun Pharmaceuticals share price and stock price with an interactive chart. Analyse FREDUN price trends, trading volume, historical performance, and volatility across different timeframes — the complete Fredun Pharmaceuticals stock quote in one place.
Fredun Pharmaceuticals Company Profile - Fundamental Screener
Screen Fredun Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for FREDUN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE194R01017
Fredun Pharmaceuticals Balance Sheet Screener
Screen FREDUN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 |
|---|---|---|
| Assets | ||
| Total Assets | 642 | 487 |
| Current Assets | 498 | 427 |
| Fixed Assets | 118 | 53 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 67 | 18 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 278 | 141 |
| Share Capital | 6 | 5 |
| Reserves & Surplus | 259 | 137 |
Fredun Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Fredun Pharmaceuticals income statement and profit fundamentals.
Analyze FREDUN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Fredun Pharmaceuticals share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 228 | 210 | 160 | 144 | 119 | 165 | 286 | 0 | 0 |
| Expenses | 196 | 184 | 135 | 123 | 103 | 150 | 251 | 0 | 0 |
| EBITDA | 32 | 26 | 25 | 21 | 17 | 15 | 35 | 0 | 0 |
| Operating Profit % | 14.00% | 12.00% | 16.00% | 14.00% | 14.00% | 9.00% | 12.00% | 0.00% | 0.00% |
| Depreciation | 4 | 3 | 2 | 2 | 1 | 2 | 3 | 0 | 0 |
| Interest | 9 | 15 | 11 | 8 | 7 | 8 | 14 | 0 | 0 |
| Profit Before Tax | 21 | 11 | 14 | 13 | 9 | 7 | 20 | 0 | 0 |
| Tax | 7 | 1 | 4 | 3 | 2 | 1 | 7 | 0 | 0 |
| Net Profit | 13 | 11 | 11 | 9 | 7 | 6 | 14 | 0 | 0 |
| EPS | 23.82 | 19.70 | 22.19 | 19.98 | 14.33 | 12.71 | 29.09 | 0.00 | 0.00 |
Fredun Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen FREDUN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March |
|---|---|---|
| Operating Activities | 12 | -17 |
| Investing Activities | -74 | -6 |
| Financing Activities | 121 | 27 |
| Net Cash Flow | 60 | 4 |
Fredun Pharmaceuticals Shareholding Pattern Screener
See Fredun Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Fredun Pharmaceuticals promoter holding and ownership changes for FREDUN on TickJournal.
| Item | 2026-Jul | 2026-Jun | 2026-Mar | 2026-Feb | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.57% | 44.57% | 44.17% | 43.06% | 43.06% | 48.93% | 48.93% | 48.93% |
| FII Holding | 1.06% | 1.06% | 1.06% | 1.06% | 0.46% | 0.01% | 0.00% | 0.00% |
| DII Holding | 2.94% | 2.94% | 2.83% | 2.89% | 3.48% | 1.60% | 1.59% | 1.59% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 43.62% | 43.79% | 44.66% | 45.63% | 45.18% | 43.74% | 44.52% | 44.50% |
| Other Holding | 7.81% | 7.65% | 7.28% | 7.37% | 7.83% | 5.72% | 4.96% | 4.98% |
| Shareholder Count | 9,598 | 8,903 | 8,400 | 8,443 | 8,749 | 8,120 | 7,906 | 7,976 |
Fredun Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Fredun Pharmaceuticals dividend history with payout and yield data.
View Fredun Pharmaceuticals dividend details including ex-dates and amounts for FREDUN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.70 | 0.05% |
| 2025-March | ₹0.70 | 0.13% |
| 2024-March | ₹0.70 | 0.31% |
| 2023-March | ₹0.70 | 0.29% |
| 2022-March | ₹0.70 | 0.27% |
| 2021-March | ₹0.70 | 0.23% |
| 2020-March | ₹0.66 | 0.43% |
| 2019-March | ₹0.65 | 1.67% |
| 2018-March | ₹1.00 | 0.71% |
| 2017-March | ₹0.60 | 1.26% |
Fredun Pharmaceuticals Stock Index Membership
See which indices include Fredun Pharmaceuticals stock.
Check FREDUN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Fredun Pharmaceuticals Market Events Screener - Corporate Actions
Get Fredun Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Fredun Pharmaceuticals stock events that may affect FREDUN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-05 | 2026-08-05 | Quarterly Result Announcement | NA | 22.33% |
| 2026-07-16 | 2026-07-16 | Bonus | 2:1 | 7.27% |
| 2026-06-30 | 2026-06-30 | Annual General Meeting | NA | 18.48% |
| 2026-06-23 | 2026-06-23 | Dividend | ₹ 0.70 /share | 1.92% |
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | 5.79% |
| 2026-02-16 | 2026-02-16 | Extraordinary General Meeting | NA | 21.57% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | 10.64% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -9.98% |
| 2025-10-22 | 2025-10-22 | Extraordinary General Meeting | NA | 27.12% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | 8.06% |
| 2025-09-23 | 2025-09-23 | Dividend | ₹ 0.70 /share | 57.68% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | 11.44% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 6.41% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 3.02% |
| 2024-10-26 | 2024-10-26 | Quarterly Result Announcement | NA | -6.18% |
Fredun Pharmaceuticals Competitors Screener - Peer Comparison
Screen FREDUN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 442,101 | 36.48 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 245,280 | 84.64 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 185,810 | 87.77 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,115 | 24.32 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 109,318 | 32.86 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 105,099 | 97.64 | 6,868 | 22.01% | 890 | 68.28 |
| Aurobindo Pharma | 96,289 | 25.98 | 34,145 | 5.56% | 3,503 | 57.04 |
| Dr Reddys Laboratories | 96,287 | 30.44 | 35,059 | 3.90% | 4,158 | 47.72 |
| Lupin | 94,844 | 17.27 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,246 | 45.49 | 14,636 | 14.85% | 1,938 | 37.57 |
Fredun Pharmaceuticals Company Announcements - News Screener
Screen FREDUN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | - | |
| Announcement under Regulation 30 (LODR)-Press Release / Media Release | - | |
| 2026-09-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-09-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-17 | Intimation Regarding Permission To Trade And Admission Of Equity Shares To Dealings On The National Stock Exchange Of India Limited. | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-14 | Statement Of Deviation Or Variation For The Quarter Ended June 30 2026 | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-05 | Outcome Of The Board Meeting | - |
| 2026-08-05 | Board Meeting Outcome for Outcome Of The Board Meeting | - |
| 2026-07-30 | Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Wednesday 05Th August 2026. | - |
| 2026-07-17 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-07-10 | Intimation Of Record Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Issue Of Bonus Equity Shares. | - |
| 2026-07-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |